The results of animal experiments uncovered that depletion of PCAT6 inhibited tumor growth by activating the T cell response in vivo, which was mainly manifested by the increase of CD3+ T cells and IFN-γ-producing CD4+ T and CD8+ T cells. The gene discussed is PCAT6; the disease is neoplasm.